)
Visual
test
SoftOx Solutions
SoftOx Solutions (SOFTX) investor relations material
SoftOx Solutions Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary25 Mar, 2026
Executive summary
Completed major organizational restructuring and strategic refocusing, with new leadership and a sharpened focus on inhaled therapeutics for chronic lung diseases and medical countermeasures against biological threats.
Clinical Trial Application for Phase 2a cystic fibrosis study approved in December 2025; first healthy volunteer dosed in March 2026.
Advanced Phase 1 program for medical countermeasures, supported by non-dilutive funding from European Defence Fund and Norwegian Ministry of Defence.
Spun off wound and skin technology to shareholders, enabling full focus on inhaled therapeutics.
Significant cost reductions and resolution of legacy commitments completed.
Financial highlights
Total operating revenue for 2025 was NOK 15.6 million, up from NOK 7.9 million in 2024, mainly from European Defence Fund and Norwegian Research Fund grants.
Total operating expenses for 2025 were NOK 27 million, down from NOK 40.4 million in 2024.
Pre-tax loss for 2025 was NOK 10.8 million, a significant improvement from NOK 50.5 million loss in 2024.
Cash and cash equivalents at year-end 2025 were NOK 19.8 million, up from NOK 10.5 million at end of 2024.
Net proceeds from equity issues in 2025 totaled NOK 19.1 million.
Outlook and guidance
Dose escalation part of the Phase 2a study expected to complete in H1 2026, with proof-of-concept stage to follow and trial conclusion in Q1 2027.
Phase 1 study for medical countermeasures to initiate in H1 2026, with results anticipated in H1 2027.
Additional GMP manufacturing planned for Q1 2026 to support ongoing clinical programs.
Anticipates meaningful clinical data within twelve months, potentially enabling partnership discussions.
What specific data points will drive partnership talks?
What is the remaining Long State facility capacity?
What are key risks to Q1 2027 PoC timeline?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from SoftOx Solutions
- Debt-free, lean team targets pivotal Phase II VAP trial and seeks NOK 60–80m funding.SOFTX
Investor Update2 Feb 2026 - Losses narrowed, liquidity improved, and clinical trials for inhaled therapeutics advance.SOFTXQ3 202526 Nov 2025
- Refocused on inhalation therapeutics, improved liquidity, and advanced clinical trial plans.SOFTXQ4 202431 Oct 2025
- Phase IIa CF trial targets major value inflection, with strong market and partnership prospects.SOFTXInvestor Update20 Oct 2025
- Losses narrowed and clinical trial plans advanced, supported by new funding and cost controls.SOFTXQ2 202517 Sep 2025
- Q1 profit achieved after restructuring, with clinical trials and funding efforts underway.SOFTXQ1 202527 Jun 2025
- Q3 loss deepened amid restructuring, with new funding and a strategic spinout planned.SOFTXQ3 202413 Jun 2025
- H1 2024 loss deepens as SoftOx restructures, raises capital, and advances antimicrobial R&D.SOFTXQ2 202413 Jun 2025
- Q1 loss widened on lower revenue and restructuring; R&D focus shifts to key clinical trials.SOFTXQ1 202413 Jun 2025
Next SoftOx Solutions earnings date
Q1 202624 Jun, 2026
SoftOx Solutions
Next SoftOx Solutions earnings date
Q1 202624 Jun, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage